Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Evgen Pharma ( (GB:TCF) ) has shared an announcement.
Theracryf PLC, a UK-based company, has announced a significant change in its voting rights structure due to an acquisition or disposal of voting rights by Rathbones Investment Management Ltd and Investec Wealth & Investment Limited. The notification indicates that the total voting rights held by these entities have decreased from 6.0347% to 1.1662%, suggesting a substantial reduction in their influence over the company’s decisions. This change could impact the company’s governance and strategic direction, potentially affecting stakeholders and market perceptions.
More about Evgen Pharma
YTD Price Performance: -56.73%
Average Trading Volume: 1,889,140
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £4.79M
For detailed information about TCF stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “…Overlook a Lack of Earnings Power”: UBS Analysts Target Intel Stock (NASDAQ:INTC), Stock Gains
- “…Significantly Extend the Reach and Lethality of our Fleet”: Boeing Stock (NYSE:BA) Slips Despite Successful MQ-25A Test
- “Direct Result of Your Feedback….” Microsoft Stock (NASDAQ:MSFT) Slips as The Option to Skip Updates Emerges